Publications of Bertram Müller-Myhsok

Binder, E. B.; Salyakina, D.; Lichtner, P.; Wochnik, G. M.; Ising, M.; Pütz, B.; Papiol, S.; Seaman, S.; Lucae, S.; Kohli, M. et al.; Nickel, T.; Künzel, H.; Fuchs, B.; Majer, M.; Pfennig, A.; Kern, N.; Brunner, J.; Modell, S.; Baghai, T.; Deiml, T.; Zill, P.; Bondy, B.; Rupprecht, R.; Messer, T.; Köhnlein, O.; Dabitz, H.; Brückl, T.; Müller, N.; Pfister, H.; Lieb, R.; Mueller, J. C.; Löhmussaar, E.; Strom, T. M.; Bettecken, T.; Meitinger, T.; Uhr, M.; Rein, T.; Holsboer, F.; Müller-Myhsok, B.: Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nature Genetics 36, pp. 1319 - 1325 (2004)

Zimprich, A.; Müller-Myhsok, B.; Farrer, M.; Leitner, P.; Sharma, M.; Hulihan, M.; Lockhart, P.; Strongosky, A.; Kachergus, J.; Calne, D. B. et al.; Stoessl, J.; Uitti, R. J.; Pfeiffer, R. F.; Trenkwalder, C.; Homann, N.; Ott, E.; Wenzel, K.; Asmus, F.; Hardy, J.; Wszolek, Z.; Gasser, T.: The PARK8 locus in autosomal dominant parkinsonism: Confirmation of linkage and further delineation of the disease-containing interval. American Journal of Human Genetics 74 (1), pp. 11 - 19 (2004)

Kern, N.; Binder, E. B.; Künzel, H. E.; Pfennig, A.; Fuchs, B.; Ising, M.; Erhardt, A.; Lucae, S.; Müller-Myhsok, B.; Modell, S. et al.; Keck, M. E.; Holsboer, F.: Is there a genetic continuum between anxiety and depression? Pharmacopsychiatry 36 (5), p. 239 - 239 (2003)

Pfennig, A.; Kuenzel, H. E.; Kern, N.; Fuchs, B.; Brunner, J.; Ising, M.; Modell, S.; Müller-Myhsok, B.; Binder, E. B.; Holsboer, F.: HPA axis dysregulation and suicidal behavior in depression - Differentiation of a genetically distinct subgroup? Pharmacopsychiatry 36 (5), pp. 252 - 253 (2003)

Winkelmann, J.; Lichtner, P.; Strom, T. M.; Trenkwalder, C.; Meitinger, T.; Müller-Myhsok, B.: Evidence for genetic heterogeneity in Restless Legs Syndrome. Pharmacopsychiatry 36 (5), p. 273 - 273 (2003)

Andlauer, T. F. M.; Müller-Myhsok, B.; Ripke, S.: Statistical genetics: genome-wide studies. In: Psychiatric genetics: a primer for clinical and basic scientists, pp. 57 - 69 (Eds. Schulze, T. G.; McMahon, F. J.). Oxford Univ. Press, New York (2018)

Renzi, C.; Provencal, N.; Bassil, K. C.; Evers, K.; Kihlbom, U.; Radford, E. J.; Koupil, I.; Mueller-Myhsok, B.; Hansson, M. G.; Rutten, B. P. F.: From Epigenetic Associations to Biological and Psychosocial Explanations in Mental Health. In: NEUROEPIGENETICS AND MENTAL ILLNESS, pp. 299 - 323 (Ed. Rutten, B. P. F.). ELSEVIER ACADEMIC PRESS, Cambridge (2018)

Müller-Myhsok, B.: Genetische Grundlagen der Wirksamkeit von Antidepressiva. Forschungsbericht 2006 - Max-Planck-Institut für Psychiatrie. In: Jahrbuch (Ed. Max-Planck-Gesellschaft). Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., München (2006)

Gola, D.; Andlauer, T.; Mirza-Schreiber, N.; Zeng, L.; Müller-Myhsok, B.; Koenig, I. R.: How well can we classify coronary artery disease using all genetic data and choosing the best classification algorithm? 27th Annual Meeting of the International Genetic Epidemiology Society (IGES), San Diego, USA, October 14, 2018 - October 16, 2018. GENETIC EPIDEMIOLOGY 42 (7), 41, pp. 701 - 702 (2018)

Anderson-Schmidt, H.; Papiol, S.; Andlauer, T.; Heilbronner, U.; Budde, M.; Kalman, J.; Degenhardt, F.; Noethen, M.; Strohmaier, J.; Frank, J. et al.; Witt, S.; Müller-Myhsok, B.; Falkai, P.; Rietschel, M.; Schulze, T. G.: USING POLYGENIC SCORES BASED ON SCHNEIDERIAN FIRST RANK SYMPTOMS TO CHARACTERIZE DISEASE TRAJECTORIES IN SEVERE MENTAL ILLNESSES. 24th World Congress of Psychiatric Genetics (WCPG 2016), Jerusalem, ISRAEL, October 30, 2016 - November 04, 2016. EUROPEAN NEUROPSYCHOPHARMACOLOGY 27 (S3), pp. S395 - S396 (2017)

Andlauer, T.; Parra, J. G.; Strohmaier, J.; Streit, F.; Frank, J.; Forstner, A. J.; Herms, S.; Ripke, S.; Müller-Myhsok, B.; Cichon, S. et al.; Cleries, F. M.; Noethen, M.; Rietschel, M.: POLYGENIC RISK FOR BIP, MDD, AND SCZ IN ANDALUSIAN MULTIPLEX FAMILIES. 24th World Congress of Psychiatric Genetics (WCPG), Jerusalem, ISRAEL, October 30, 2016 - November 04, 2016. EUROPEAN NEUROPSYCHOPHARMACOLOGY 27 (S3), M28, pp. S385 - S386 (2017)

Carrillo-Roa, T.; Boadie, D.; McGrath, C.; Müller-Myhsok, B.; Craighed, E.; Mayberg, H.; Binder, E.: POLYGENIC SCORES DERIVED FROM NEUROIMAGING ENDOPHENOTYPES PREDICT OUTCOMES TO PSYCHOTHERAPY AND MEDICATION TREATMENTS FOR MAJOR DEPRESSIVE DISORDER. 24th World Congress of Psychiatric Genetics (WCPG), Jerusalem, ISRAEL, October 30, 2016 - November 04, 2016. EUROPEAN NEUROPSYCHOPHARMACOLOGY 27 (S3), p. S486 - S486 (2017)

Forstner, A. J.; Wolf, C.; Maron, E.; Erhardt, A.; Eriksson, E.; Hovatta, L.; Lavebratt, C.; Allgulander, C.; Woldbye, D. P. D.; Mors, O. et al.; Müller-Myhsok, B.; Binder, E. B.; Rueck, C.; Deckert, J.; Schumacher, J.: GENOME-WIDE ASSOCIATION STUDY OF PANIC DISORDER. 23rd Annual World Congress of Psychiatric Genetics (WCPG), Toronto, CANADA, October 16, 2015 - October 20, 2015. EUROPEAN NEUROPSYCHOPHARMACOLOGY 27 (Suppl.2), Su19, pp. S217 - S218 (2017)

Iurato, S.; Carrillo-Roa, T.; Arloth, J.; Czamara, D.; Ising, M.; Lucae, S.; Müller-Myhsok, B.; Binder, E.; Erhardt, A.: SEX-SPECIFIC DNA METHYLATION SIGNATURES IN PANIC DISORDER. 24th World Congress of Psychiatric Genetics (WCPG), Jerusalem, ISRAEL, October 30, 2016 - November 04, 2016. EUROPEAN NEUROPSYCHOPHARMACOLOGY 27 (Suppl. 3), T24, pp. S446 - S447 (2017)

Karbalai, N.; Czamara, D.; Moll, K.; Ramus, F.; Malik, R.; Scerri, T. S.; Schumacher, J.; Morris, A. P.; Bourgeron, T.; Monaco, A. P. et al.; Paracchini, S.; Fisher, S. E.; Nothen, M.; Schulte-Korne, G.; Müller-Myhsok, B.: IDENTIFICATION OF GENETIC INTERACTIONS INVOLVED IN DYSLEXIA PATHOGENESIS. 23rd Annual World Congress of Psychiatric Genetics (WCPG), Toronto, CANADA, October 16, 2015 - October 20, 2015. EUROPEAN NEUROPSYCHOPHARMACOLOGY 27 (Suppl. 2), Sa68, pp. S183 - S184 (2017)

Zannas, A. S.; Gassen, N. C.; Jia, M.; Baumert, J.; Hafner, K.; Ködel, M.; Haehle, A.; Iurato, S.; Carrillo-Roa, T.; Emeny, R. T. et al.; Lahti, J.; Raikkönen, K.; Eriksson, J.; Drake, A.; Waldenberger, M.; Wahl, S.; Kunze, S.; Lucae, S.; Bradley, B.; Gieger, C.; Hausch, F.; Smith, A. K.; Ressler, K. J.; Ludwig, K.-H.; Müller-Myhsok, B.; Rein, T.; Binder, E. B.: Aging- and stress-related epigenetic disinhibition of FKBP5 contributes to NF-κB-driven inflammation and cardiovascular risk. Conference of the World-Association-for-Stress-Related-and-Anxiety-Disorders (WASAD), Würzburg, Germany, September 14, 2017 - September 16, 2017. JOURNAL OF NEURAL TRANSMISSION 124 (10), p. 1292 - 1292 (2017)

Zannas, A.; Jia, M.; Baumert, J.; Hafner, K.; Ködel, M.; Hähle, A.; Iurato, S.; Carrillo Roa, T.; Emeny, R.; Lathi, J. et al.; Raikkonen, K.; Eriksson, J.; Drake, A.; Waldenberger, M.; Wahl, S.; Kunze, S.; Lucae, S.; Bradley, B.; Gieger, C.; Hausch, F.; Smith, A.; Ressler, K.; Müller-Myhsok, B.; Ladwig, K.-H.; Rein, T.; Gassen, N.; Binder, E.: Aging- and Stress-Related Epigenetic Disinhibition of FKBP5 Contributes to NF-KB-Driven Inflammation and Cardiovascular Risk. 56th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP), Palm Springs, CA, December 03, 2017 - December 07, 2017. NEUROPSYCHOPHARMACOLOGY 42 (Suppl. 1), T26, pp. S310 - S311 (2017)

Abbondanza, F.; Gialluisi, A.; Moll, K.; Vreeker, A.; Cecil, C.; Muller-Myhsok, B.; Schulte-Korne, G.; Whitehouse, A.; Wang, C.; Pennell, C. et al.; De Jong, P. F.; Van Bergen, E.; Alrouh, H.; Boomsma, D.; Michaelson, J. J.; Casten, L.; Eising, E.; Malanchini, M.; Wigg, K.; Price, K.; Barr, C.; McBride, C.; Paracchini, S.: Large-scale genomic meta-analysis on math abilities in cohorts of 20,000 participants. In EUROPEAN JOURNAL OF HUMAN GENETICS, 31, p. 341 - 341. (2023)

Fu, X.; Mueller-Myhsok, B.; Puetz, B.: Identification of transdiagnostic HIV-related Cryptococcosis by machine learning. In HIV MEDICINE, 24, pp. 467 - 468. (2023)

Fu, X.; Wu, L.; Puetz, B.; Muller-Myhsok, B.: Risk factor predictions for threeyear mortality among HIV-related patients with disseminated Cryptococcosis. In HIV MEDICINE, 24, pp. 619 - 620. (2023)